Embargo: Immediate release Pretoria, 20 July 2022 – The South African Health Products Regulatory Authority (SAHPRA) has noted the numerous media articles on the statement made by Minister Sisulu, having secured medicine for the late Jessie Duarte. To this effect, SAHPRA is looking into the reports...
10 September 2021 The South African Health Products Authority (SAHPRA) has approved the use of the Pfizer COMIRNATY Vaccine in terms of Section 21 of the Medicines and Related Substance Act 101 of 1965 (The Medicines Act) to include individuals twelve years (12) years and older....
3 September 2021 The South African Health Products Regulatory Authority (SAHPRA) is aligned with the United States Food and Drug Administration (USFDA) call to not use Ivermectin for the treatment of COVID-19. This stance is reflected in the SAHPRA statement, dated 28 January 2021, outlining SAHPRA’s views on Ivermectin and the Controlled Compassionate Use Programme. SAHPRA...
07 June 2021 To whom it may concern We draw your attention to the provisions of Section 21 of the Medicine and Related Substances Act, 1965 (Act 101 of 1965), to authorise the sale of unregistered medicines or medical devices for certain purposes. The communication...
29 March 2021 The SABC placed an erroneous report that “SAHPRA has agreed to allow the use of Ivermectin for the treatment of COVID-19”. This is grossly untrue, misleading to the public and irresponsible and could have dire consequences. The position of SAHPRA remains steadfast. Ivermectin may...
19 March 2021 SAHPRA has implemented a new and improved online submission portal for Section 21 applications (Category A Medicines). This has been in development over the past few months. The new submission portal will improve the communication timelines between SAHPRA and applicants. It also allows the...
